Search Results - "Liguori, M. J."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Evaluation of miR-122 as a Serum Biomarker for Hepatotoxicity in Investigative Rat Toxicology Studies by Sharapova, T., Devanarayan, V., LeRoy, B., Liguori, M. J., Blomme, E., Buck, W., Maher, J.

    Published in Veterinary pathology (01-01-2016)
    “…MicroRNAs are short noncoding RNAs involved in regulation of gene expression. Certain microRNAs, including miR-122, seem to have ideal properties as biomarkers…”
    Get full text
    Journal Article
  2. 2

    Reduced hepatic global hydroxymethylation in mice treated with non-genotoxic carcinogens is transiently reversible with a methyl supplemented diet by Sharapova, T., Talaty, N., Buck, W.R., Fossey, S., Liguori, M.J., Van Vleet, T.R.

    Published in Toxicology and applied pharmacology (15-03-2021)
    “…Non-genotoxic carcinogens (NGCs) are known to cause perturbations in DNA methylation, which can be an early event leading to changes in gene expression and the…”
    Get full text
    Journal Article
  3. 3

    Recombinant human interleukin-6 enhances the immunoglobulin secretion of a rabbit-rabbit hybridoma by Liguori, M J, Hoff-Velk, J A, Ostrow, D H

    Published in Hybridoma (01-06-2001)
    “…The generation of stable rabbit-rabbit hybridomas is now possible by the recent development of a rabbit fusion partner. The ability to generate rabbit…”
    Get more information
    Journal Article
  4. 4

    Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals by Van Vleet, Terry R, Liguori, Michael J, Lynch, 3rd, James J, Rao, Mohan, Warder, Scott

    Published in SLAS discovery (01-01-2019)
    “…Pharmaceutical discovery and development is a long and expensive process that, unfortunately, still results in a low success rate, with drug safety continuing…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7

    Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin by LIGUORI, Michael J, ANDERSON, Mark G, BUKOFZER, Stanley, MCKIM, Jan Es, PREGENZER, Jeffrey F, RETIEF, Jacques, SPEAR, Brian B, WARING, Jeffrey F

    Published in Hepatology (Baltimore, Md.) (2005)
    “…Idiosyncratic drug toxicity, defined as toxicity that is dose independent, host dependent, and usually cannot be predicted during preclinical or early phases…”
    Get full text
    Journal Article
  8. 8

    Investigations toward enhanced understanding of hepatic idiosyncratic drug reactions by Liguori, Michael J, Waring, Jeffrey F

    “…Idiosyncratic drug reactions (IDRs) of a hepatic origin are a major health concern and a notoriously difficult challenge for the pharmaceutical industry. These…”
    Get more information
    Journal Article
  9. 9

    Global transcriptomic profiling using small volumes of whole blood: a cost-effective method for translational genomic biomarker identification in small animals by Fricano, Meagan M, Ditewig, Amy C, Jung, Paul M, Liguori, Michael J, Blomme, Eric A G, Yang, Yi

    “…Blood is an ideal tissue for the identification of novel genomic biomarkers for toxicity or efficacy. However, using blood for transcriptomic profiling…”
    Get full text
    Journal Article